- Active Pharmaceutical Ingredients
- Varenicline tartrate
- Aprepitant, Fosapitant Intermediates
- Fosaprepitant Dimeglumine
- Vildagliptin
- Efinaconazole
- Luliconazole Intermediate
- Gadoterate Meglumine
- Succinyl Alcohol Intermediate
- Mirabillon Intermediate
- Atazanavir Intermediate
- Intermediate
- Varenicline tartrate
- Aprepitant 287930-73-8
- Aprepitant 127852-28-2
- Aprepitant 287930-75-0
- Aprepitant 200000-59-5
- Aprepitant 155742-64-6
- Aprepitant 252742-72-6
- Fosaprepitant Dimeglumine 990-91-0
- Fosaprepitant Dimeglumine 265121-01-5
- Vildagliptin 207557-35-5
- Vildagliptin 702-82-9
- Efinaconazole 144230-50-2
- Efinaconazole 133775-25-4
- Efinaconazole 127000-90-2
- Gadoterate Meglumine
- Mirabegron
- Luliconazole 98873-55-3
- Luliconazole 126534-31-4
- Atazanavir sulfate
- Bortezomib 179324-87-9
- Bortezomib 114457-94-2
- Bortezomib 205393-22-2
- Brinzolamide
- Rivaroxaban Intermediate 446292-08-6
- Rivaroxaban Intermediate 446292-07-5
- Cinacalcet Hydrochloride 1005450-55-4
- Cinacalcet Hydrochloride 585-50-2
- Eletriptan Intermediate
- Indacaterol intermediate 312753-53-0
- Indacaterol intermediate 173140-90-4
- Sitagliptin Intermediate
- Fosanavir Calcium Intermediate
Popular information
Glaucoma medication Brinzolamide 138890-62-7
【Catalog number】AP0900
【CAS #】 138890-62-7
【Molecular formula】 C12H21N3O5S3
【Product Brief】US-DMF No. 22851 Brinzolamide, English name is Brinzolamide, American Chemical Abstracts Registration Number is cas 138890-62-7.
Glaucoma medication
Brinzolamide
CAS # 138890-62-7
US-DMF No. 22851
Alias (R)-(+)-4-Ethylamino-2- (3-methoxypropyl) -3,4-dihydro-2H-thieno [3,2-e] -1,2-thia Azine-6-sulfonamide-1,1-dioxide; (R)-(+)-4- (ethylamino) -3,4-dihydro-2- (3-methoxypropyl) -2H- Thiophene [3,2-E] -1,2-thiazine-6-sulfamoyl 1,1-dioxide; parizolid
Catalog number AP0900
CAS # 138890-62-7
Molecular formula C12H21N3O5S3
Molecular weight 383.51
Structural formula
Product introduction
CAS 138890-62-7
US-DMF No. 22851 Brinzolamide, English name is Brinzolamide, American Chemical Abstracts Registration Number is cas 138890-62-7.
Brinzolamide (cas 138890-62-7) is used to treat primary and secondary open-angle glaucoma and ocular hypertension. It can also be used to prevent the increase of intraocular pressure after laser surgery. Can be used as a single treatment drug for patients who are ineffective against β-blockers, or have contraindications to use, or as a synergistic treatment for β-blockers.
VIWIT 沪ICP备12014533号-1
